References
- 1. Hara K, Shojima N, Hosoe J, Kadowaki T. Genetic architecture of type 2 diabetes. Biochem Biophys Res Commun. 2014;452(2):213-20. DOI: 10.1016/j.bbrc.2014.08.012.
- 2. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. The Lancet. 2005;365(9467):1333-46. DOI: 10.1016/S0140-6736(05)61032-X.
- 3. Saravani R, Esmaeeli E, Tamendani MK, Nejad MN. Oxytocin Receptor Gene Polymorphisms in Patients With Diabetes. Gene Cell Tissue. 2015;2(2): e27904. DOI: 10.17795/gct-27904.
- 4. Tahrani AA, Piya MK, Kennedy A, Barnett AH. Glycaemic control in type 2 diabetes: targets and new therapies. Pharmacol Ther. 2010;125(2):328-61. DOI: 10.1016/j.pharmthera.2009.11.001.
- 5. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. The Lancet. 2011;378(9786):169-81. DOI: 10.1016/S0140-6736(11)60614-4.
- 6. Allahdini M, Kamalidehghan B, Akbari L, Azadfar P, Rahmani A, Ahmadipour F, et al. Prevalence of the rs7903146C> T polymorphism in TCF7L2 gene for prediction of type 2 diabetes risk among Iranians of different ethnicities. Drug Des Devel Ther. 2015;9:5835.
- 7. Guja C, Gagniuc P, Ionescu-Tîrgovişte C, editors. Genetic factors involved in the pathogenesis of type 2 diabetes. Proc Rom Acad Series B; 2012.
- 8. Zhou Y, Park S-Y, Su J, Bailey K, Ottosson-Laakso E, Shcherbina L, et al. TCF7L2 is a master regulator of insulin production and processing. Hum Mol Gen. 2014:ddu359.
- 9. Mayans S, Lackovic K, Lindgren P, Ruikka K, Ågren Å, Eliasson M, et al. TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden. Eur J Hum Genet. 2007;15(3):342-6. DOI: 10.1038/sj.ejhg.5201773.
- 10. Klünder-Klünder M, Mejía-Benitez MA, Flores-Huerta S, Burguete-García AI, García-Mena J, Cruz M. rs12255372 variant of TCF7L2 gene is protective for obesity in Mexican children. Arch Med Res. 2011;42(6):495-501. DOI: 10.1016/j.arcmed.2011.05.006.
- 11. Palmer ND, Lehtinen AB, Langefeld CD, Campbell JK, Haffner SM, Norris JM, et al. Association of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans. J Clin Endocrinol Metab. 2008;93(1):304-9. DOI: 10.1210/jc.2007-1225.
- 12. Amoli MM, Amiri P, Tavakkoly-Bazzaz J, Charmchi E, Hafeziyeh J, Keramatipour M, et al. Replication of TCF7L2 rs7903146 association with type 2 diabetes in an Iranian population. GENET MOL BIOL. 2010;33(3):449-51. DOI: 10.1590/S1415-47572010005000056.
- 13. Cauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, Weitgasser R, et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med. 2007;85(7):777-82. DOI: 10.1007/s00109-007-0203-4.
- 14. Barra GB, Dutra LAS, Watanabe SC, Costa PGG, Cruz PSMd, Azevedo MF, et al. Association of the rs7903146 single nucleotide polymorphism at the Transcription Factor 7-like 2 (TCF7L2) locus with type 2 diabetes in Brazilian subjects. Arq Bras Endocrinol Metab. 2012;56(8):479-84. DOI: 10.1590/S0004-27302012000800003.
- 15. Wegner L, Hussain MS, Pilgaard K, Hansen T, Pedersen O, Vaag A, et al. Impact of TCF7L2 rs7903146 on insulin secretion and action in young and elderly Danish twins. J Clin Endocrinol Metab. 2008;93(10):4013-9. DOI: 10.1210/jc.2008-0855.
- 16. Luo Y, Wang H, Han X, Ren Q, Wang F, Zhang X, et al. Meta-analysis of the association between SNPs in TCF7L2 and type 2 diabetes in East Asian population. Diabetes Res Clin Pract. 2009;85(2):139-46. DOI: 10.1016/j.diabres.2009.04.024.
- 17. Ng MC, Tam CH, Lam VK, So W-Y, Ma RC, Chan JC. Replication and identification of novel variants at TCF7L2 associated with type 2 diabetes in Hong Kong Chinese. J Clin Endocrinol Metab. 2007;92(9):3733-7. DOI: 10.1210/jc.2007-0849.
- 18. Tangjittipokin W, Chongjarean N, Plengvidhya N, Homsanit M, Yenchitsomanus P-t. Transcription factor 7-like 2 (TCF7L2) variations associated with earlier age-onset of type 2 diabetes in Thai patients. J Genet. 2012;91(2):251-5. DOI: 10.1007/s12041-012-0176-0.
- 19. Qiao H, Zhang X, Zhao X, Zhao Y, Xu L, Sun H, et al. Genetic variants of TCF7L2 are associated with type 2 diabetes in a northeastern Chinese population. Gene. 2012;495(2):115-9. DOI: 10.1016/j.gene.2011.12.055.
- 20. Chang Y-C, Chang T-J, Jiang Y-D, Kuo S-S, Lee K-C, Chiu KC, et al. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population. Diabetes. 2007;56(10):2631-7. DOI: 10.2337/db07-0421.
- 21. Hayashi T, Iwamoto Y, Kaku K, Hirose H, Maeda S. Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese population. Diabetologia. 2007;50(5):980-4. DOI: 10.1007/s00125-007-0618-z.
- 22. Horikoshi M, Hara K, Ito C, Nagai R, Froguel P, Kadowaki T. A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population. Diabetologia. 2007;50(4):747-51. DOI: 10.1007/s00125-006-0588-6.
- 23. Pang D, Smith A, Humphries S. Functional analysis of TCF7L2 genetic variants associated with type 2 diabetes. Nutr Metab Cardiovasc Dis. 2013;23(6):550-6. DOI: 10.1016/j.numecd.2011.12.012.
- 24. Karnes JH, Gong Y, Pacanowski MA, McDonough CW, Arwood MJ, Langaee TY, et al. Impact of TCF7L2 single nucleotide polymorphisms on hydrochlorothiazide-induced diabetes. Pharmacogenet Genomics. 2013;23(12):697. DOI: 10.1097/FPC.0000000000000012.